Mark Your Calendar
Reversing Heart Disease
Feb. 27
Transcranial Doppler Ultrasound for Comprehensive Stroke Care
March 14—March 16
Virtual Medicine Symposium
March 28—March 29
Surgery Grand Rounds
See information about upcoming Surgery Grand Rounds.
Grand Rounds
Education Schedule
Surgery Scheduling
In This Issue:
- Affiliation of Cedars-Sinai and Torrance Memorial Official
- Two Minutes With …
- $50 Million Gift Goes to Create Smidt Heart Institute
- Easier, More Meaningful Advance Healthcare Directive
- Study Looks at Sudden Cardiac Arrest in Young People
- Transplant Saves Bishop at the Heart of His Community
- Stop the Bleed Class Trains its 500th Student
- Cardiac Surgery Resident Awarded Traveling Fellowship
- Hosting Summer Research Interns
- Circle of Friends Honorees for January
- Stenting System Benefits Certain Stroke Patients
- FDA Updates Warning About Antidepressant Pristiq
- FDA Issues Warning About Incorrect Dosing of Obeticholic Acid
- CS-Link Tip: Refilling Prescriptions
FDA Updates Warning About Antidepressant Pristiq
The U.S. Food and Drug Administration has updated a warning about the antidepressant Pristiq (desvenlafaxine succinate) that it can lead to serotonin syndrome, a potentially life-threatening condition. The risk of suicidal thoughts and behaviors in pediatric and young adult patients is increased when used with other drugs that impair metabolism of serotonin.
The FDA has more information.